Assetmark »

Dyne Therapeutics shares owned by Assetmark

Quarter-by-quarter ownership of Dyne Therapeutics (DYN) shares owned by Assetmark from 13F filings

Historical chart of Assetmark investment in Dyne Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Dyne Therapeutics held by Assetmark consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Dyne Therapeutics by Assetmark

Quarter filed Position value Share count Share price at filing
2026-03-31 $563k 31k 18.13

More positions owned by Assetmark

Vanguard World Mega Grwth Ind (MGK)
Vanguard World Mega Cap Val Etf (MGV)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
NVIDIA Corporation (NVDA)
Pimco Etf Tr Enhan Shrt Ma Ac (MINT)
Vanguard Index Fds Sm Cp Val Etf (VBR)
Vanguard Index Fds Mcap Vl Idxvip (VOE)
Ishares Tr Core Msci Eafe (IEFA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl A (GOOGL)
Ishares Core Msci Emkt (IEMG)
Ishares Tr Us Treas Bd Etf (GOVT)
Spdr Series Trust State Street Spd (JNK)
Ishares Tr Iboxx Hi Yd Etf (HYG)

View all positions for Assetmark

Top funds holding Dyne Therapeutics

T. Rowe Price Investment Management
Henderson Group
BlackRock
Vanguard Group
Atlas Venture Life Science Advisors
Orbis Allan Gray
State Street Corporation
FMR
Vanguard Capital Management
Fcpm Iii Services B.v.
Adage Capital Partners GP
Perceptive Advisors
TCG Crossover Management
Vanguard Portfolio Management
Vestal Point Capital

View all funds holding Dyne Therapeutics